Ko te NA Semax Amidate he tairitenga-whakapaipaihia o kihai i rongo. Ko te N-mutu acetylated me te C-whakamutunga whakahiato o te Semax peptide, e pupuri ana i te raupapa matua.
Ko tenei whakarereketanga hangai ka tino whakapai ake i te aukati o te mekameka peptide ki te exo- me nga endopeptidase (hei tauira leucine aminopeptidase), te whakaroa i te haurua o te ora 30 meneti ka whakaritea ki te Semax taketake, me te roanga katoa o te mahi o 6-12 haora.
Ka whakanui hoki i te pumau o te rokiroki o te pāmahana rūma me te pai o te whakauru mucosal nasal, na reira whakarite kia pono ake te urunga o te arai toto-roro (BBB) me te pupuri tonu i te whai hua rōnaki kukū i roto i te kiko roro.
Ko tana tikanga matua kei roto i te whakarereketanga ara-maha o pūnaha io pokapū mahi.
Tuatahi me te tuatahi, Ko NA Semax Amidate e mahi ana hei kaiwhakahaere kaha o te take neurotrophic i ahu mai i te roro (BDNF), e whakanui ana i te oranga neuronal, tipu axonal, te kirihou synaptic a potentiation mo te wa roa (LTP) — te turanga ngota mo te ako me te mahara.
I tua atu,NA Semax Amidate ka kaha te dopaminergic, serotonergic, me te neurotransmission noradrenergic, na reira ka arotau uho mua nga mahi whakahaere, tae atu ki te whiriwhiri aro me mahara mahi kaha.
Ko te NA Semax Amidate hoki e whakaatu ana i nga paanga neuroprotective nui ma te whakakore i te tuku cytokine inflammatory, te whakaiti i te kino o te ahotea oxidative, me te whakapumau i te kaha membrane mitochondrial.
He whai hua ki nga momo kino pathological penei i te ischemia roro, hypoxia, mamae, a neurodegeneration.
Kua whakaaetia i Russia hei rongoa taapiri mo te mate whakapeka whiu, whara roro mamae, me te waahi tuatahi mate a Parkinson.
Hei whakarāpopototanga, Ka whakamahia e NA Semax Amidate nga whakarereketanga matū ki te hinga i nga here o te peptide taiao, na reira ka nui ake i te Semax tikanga i roto te whakapakari hinengaro, neuroprotection, whakaritenga huru, me te whakatikatika i nga whara.
He tino hiranga haumanu tenei mo te maimoatanga o nga mate neurodegenerative me te whakatairanga i te whakaora mahi o te punaha nerve pokapū.
Raupapa
AC-met-glu-tana-phe-pro-gly-pro-nh2
Tau CAS
/
Tātai rāpoi
C39H54N10O10S
Taumaha rāpoi
854.98
Rangahau o NA Semax Amidate
Ko te NA Semax Amidate e whakaatu ana i te whai huatanga e rite ana ki te puāwaitanga anxiolytic raau taero i roto i te maha o nga tauira preclinical.
1.Te Whakanui Hinengaro me te Neural Plasticity
NA Semax Amidate ka whakahohe i te take tuhi CREB, whakatikatika BDNF whakaaturanga ira me te whakanui ake i nga taumata BDNF neuronal i runga ake 40%.
Ma tenei ka whakatairanga tuawhenua dendritic hangahanga, aratohu axonal, me te whakahiato o te pūmua kiato postsynaptic 95 (PSD-95), na reira ka whakarei ake i te kaha ako.
Ko nga whakamatautau whakataihanga koiora e whakaatu ana i a 35-50% te whakapai ake i nga reiti pupuri mahara i roto i te horopaki whakamau wehi whakamātautau.
Porohia roro electrophysiological ka whakapumautia nga rekoata kua piki ake LTP kaha kaha me te roa, e tohu ana ka huri ano te NA Semax Amidate te kirihou synaptic paepae na roto i te whakahoaho hohonu o te tauwehe neurotrophic whatunga.
2.Neuroprotection me te Whakatikatika
NA Semax Amidate ka whakahohe i te adenylate cyclase (AC)-ara cAMP-PKA ki te whakau mitochondrial te kaha membrane, te aukati cytochrome C tuku, me te pehi caspase-3 whakahohenga cascade, na reira ka aukati i te wahanga mahi o apoptosis.
I te wa kotahi, ka whakatika superoxide dismutase te whakapuaki me te aukati i te mumura nui cytokine hangahanga.
I roto i te kiore te uaua o waenganui tauira occlusion, i iti iho mate roro rōrahi i runga 50%.
I roto i tetahi MPTP tauira o te mate Parkinson, i nui haere dopaminergic ora neuron e 35%, e whakaatu ana i te neuroprotection kaha.
3.Anxiolytic and Analgesic Pānga
Ko te NA Semax Amidate ka whakanui ake i te hononga mo te mutunga enkephalins a β-endorphin i te aukati G kinase receptor-honoa pūmua (Kariki)-takawaenga o roto o te kaiwhiwhi me te whakaheke, na reira ka whakaroa whakamaroke tohu tohu.
Ka whakahekehia ano hoki e te FTO-mediated inflammatory pain hypersensitivity.
I roto i nga tauira kiore, paepae mamae i whakanuia e 30-40% a ka noho teitei mo 4 ki 6 haora.
I roto i te whara constriction mau tonu (CCI) tauira, miihini allodynia i whakaitihia e 50%, me te whakapumau i nga ahuatanga o te NA Semax Amidate me te whakapumau i nga ahuatanga.
Ko te NA Semax Amidate e whakaatu ana i te kaha e rite ana ki nga raau taero anxiolytic puāwaitanga i roto i nga tauira preclinical..
4.Te Whakanui Hinengaro me te Neural Plasticity
NA Semax Amidate ka whakahohe i te take tuhi CREB, te whakatikatika i te whakaaturanga ira BDNF me te whakanui ake i nga taumata BDNF neuronal 40%.
Ma tenei ka whakatairanga i te hanganga o te tuara dendritic, aratohu axonal, me te whakahiato o te pūmua kiato postsynaptic 95 (PSD-95), na reira ka whakarei ake i te kaha ako.
Ko nga whakamatautau whakataihanga koiora e whakaatu ana i a 35-50% te whakapai ake i nga reeti pupuri mahara i roto i nga whakamatautau whakamaarama mataku.
Ko nga rekoata electrophysiological tapatapahi roro e whakau ana i te pikinga o te kaha kaha me te roa o te LTP, e tohu ana ka whakahouhia e NA Semax Amidate nga paepae kirihou synaptic na roto i te whakahoahoatanga o te whatunga tauwehe neurotrophic..
5.Neuroprotection me te Whakatikatika
NA Semax Amidate ka whakahohe i te adenylate cyclase (AC)-ara cAMP-PKA ki te whakapumau i te pumanawa membrane mitochondrial, ka aukati i te tuku cytochrome C, me te pehi i te caspase-3 cascade activation, na reira ka aukati i te wahanga mahi o te apoptosis.
I te wa kotahi, ka whakatika i te whakaaturanga superoxide dismutase me te aukati i te hanga cytokine inflammatory nui.
I roto i te tauira occlusion cerebral artery kiore waenga, i whakaitihia te nui o te mate o te roro 50%.
I roto i te tauira MPTP o te mate Parkinson, nui haere te reira dopaminergic neuron ora e 35%, e whakaatu ana i te neuroprotection kaha.
6.Anxiolytic and Analgesic Pānga
Ko te NA Semax Amidate ka whakanui ake i te hononga mo nga enkephalins endogenous me te β-endorphin i te wa e aukati ana i te kinase receptor-hononga G. (Kariki)-takawaenga o roto o te kaiwhiwhi me te whakaheke, na reira ka roa te tohu analgesic.
Ka whakahekehia ano hoki e te FTO-mediated inflammatory pain hypersensitivity.
I roto i nga tauira kiore, i whakanuia nga paepae mamae e 30-40% a ka noho teitei mo 4 ki 6 haora.
I roto i te whara constriction mau tonu (CCI) tauira, i whakaitihia te allodynia miihini e 50%, me te whakapumau i nga ahuatanga o te NA Semax Amidate me te whakapumau i nga ahuatanga.
COA
HPLC
MS





